I guess my backup clinic is doing a clinical trial to see if Rituxan would be an effective treatment for Primary Progressive Multiple Sclerosis. It will be interesting to see how this will turn out, certainly people that suffer PP or PR desperately need a good treatment for their disease progression since the ABCR drugs don’t seem to work well. On a side note the fact that the ABCR drugs don’t work seems really bizarre to me. I know that those are definitely identified as a very different disease than relapsing remitting, but to me it just sounds like a more aggressive form so just a different pathology. Hopefully a cure for one will be a cure for all. Article: UT Southwestern lead site for study of a new multiple sclerosis drug. On a side note Kathleen Hawker was who I thought I was going to be seeing when I went to the MS clinic, but that wasn’t the case. Of course she is the one who is supposedly leaving this year.